Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Updated
Women living with HIV and using antiretroviral therapy (ART). Women using Non-nucleoside/ nucleotide reverse transcriptase inhibitors (NNRTIs) containing efavirenz can generally use combined hormonal contraceptives (CHCs), progestogen-only pills (POPs), progestogenonly injectables (POIs) (norethisterone enanthate [NETEN])
Certainty of evidence
Very low
Notes and Remarks
Some data suggest potential drug interactions between EFV and some hormonal contraceptives. These interactions may reduce the effectiveness of the hormonal contraceptive.